ACTILYSE 20MG INJECTION

ACTILYSE 20MG INJECTION is most effective when administered within the recommended time window and in specific cases of acute ischemic stroke, pulmonary embolism, or acute myocardial infarction. Its use must be carefully evaluated on a case-by-case basis by qualified healthcare professionals.

ACTILYSE 20MG INJECTION is contraindicated in certain conditions, such as active bleeding, recent major surgery, intracranial hemorrhage, known hypersensitivity to it, and other situations with an increased risk of bleeding.

Before administering ACTILYSE 20MG INJECTION, healthcare professionals typically perform brain imaging (CT or MRI) to rule out hemorrhagic stroke, which is a contraindication for this medication use. They may also conduct blood tests to assess coagulation parameters and ensure that the patient meets the necessary criteria for treatment.

There is no specific reversal agent for ACTILYSE 20MG INJECTION. In case of severe bleeding complications, healthcare professionals may use supportive measures, blood products, or other interventions to manage bleeding. Close monitoring and immediate medical attention are essential to address any adverse events promptly.

ACTILYSE 20MG INJECTION is not approved for use in children or adolescents for stroke treatment. Its use in this population is limited to specific cases and requires expert evaluation and consideration of the risks and benefits.

It's important to inform your doctor about all medications you are currently taking, including prescription and over-the-counter drugs, as ACTILYSE 20MG INJECTION can interact with certain substances, particularly those affecting blood clotting. Your healthcare professional will assess potential interactions.

Always consult a healthcare professional before starting or making any changes to your medication regimen. Inform your doctor about conditions like bleeding disorders, recent surgery or trauma, gastrointestinal bleeding, or other conditions that may increase bleeding risk. Close monitoring of patients is required throughout treatment to detect any bleeding or adverse reactions promptly. It should be used in a hospital setting with access to emergency facilities, and immediate medical care must be available in case of complications. Pregnancy and breastfeeding women should consult a doctor before starting treatment. Advanced age can increase the risk of bleeding complications with this medication, particularly in patients over 75. Dosage adjustment may be required in elderly patients.

The main active ingredient in ACTILYSE 20MG INJECTION is ALTEPLASE.

ACTILYSE 20MG INJECTION is prescribed for certain conditions including specific heart disorders like acute myocardial infarction (heart attack) and pulmonary embolism (blood clot in the lungs).